Kaldvík AS Announces Leadership Change with New Interim CEO

Leadership Transition at Kaldvík AS
Kaldvík AS has announced a significant change in its leadership as Roy-Tore Rikardsen steps down as CEO. This decision has been mutually agreed upon by Rikardsen and the company’s Board of Directors, initiating a new chapter for the organization.
Interim CEO Appointment
Following Rikardsen's departure, the Board has appointed Vidar Aspehaug to serve as the interim CEO. Aspehaug brings valuable experience to the role, having joined Kaldvík AS in 2022. Over the past three years, he has been integral to the executive management, specifically overseeing the fish health and quality management teams.
About Vidar Aspehaug
Aspehaug holds a doctor’s degree in fish health from the University of Bergen and is considered a prominent figure in the industry. He founded PatoGen AS, a leading fish health laboratory in Norway, where he served as CEO and CBDO. His profound expertise will guide Kaldvík AS during this transitional phase.
Recognition of Roy-Tore Rikardsen
Asle Rønning, the chair of the Board, expressed gratitude towards Rikardsen, highlighting his contributions during the challenging transitional period after the previous CEO's resignation. Rikardsen himself acknowledged the teamwork and dedication of his colleagues, expressing optimism about the future of Kaldvík AS and the Icelandic fish farming industry.
Future Prospects
Rikardsen will remain associated with Kaldvík AS until the end of February 2026, ensuring a smooth transition for the new leadership. The Board is committed to finding a permanent CEO to lead the company into its next growth phase.
About Kaldvík AS
Kaldvík AS stands as the foremost salmon farmer in Iceland, boasting a highly developed and fully integrated value chain. This structure allows the company to manage every aspect, from the hatchery to sales, ensuring customers receive sustainable, high-quality products. Kaldvík AS is dual-listed on Euronext Growth Oslo and First North Iceland Growth Market, demonstrating its robust market position.
Contact for Further Information
For any inquiries, please reach out to Robert Robertsson, the CFO, at +354 843 0086.
Frequently Asked Questions
Who is the new interim CEO of Kaldvík AS?
Vidar Aspehaug has been appointed as the interim CEO following Roy-Tore Rikardsen's departure.
What experience does Vidar Aspehaug have?
Aspehaug holds a doctorate in fish health and has previously founded a leading fish health laboratory in Norway.
How long will Roy-Tore Rikardsen remain with the company?
Rikardsen will be available to Kaldvík AS until the end of February 2026 to ensure a smooth transition.
What is Kaldvík AS known for?
Kaldvík AS is recognized as the leading salmon farmer in Iceland with a fully integrated value chain.
Where can I find more information about Kaldvík AS?
Additional information can be found on the company's official website.
About The Author
Contact Caleb Price privately here. Or send an email with ATTN: Caleb Price as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.